Overview

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Status:
Unknown status

Trial end date:
2021-02-28

Target enrollment:

Participant gender:

Summary

A phase 3,double-blinded, double dummy, parallel, non-inferiority, randomised controlled multicenter trial to evaluate efficacy and safety of 4 weeks treatment of Anaprazole 20mg QD compared with rabeprazole 10mg QD in patients with duodenal ulcers.

Phase:

Phase 3

Details

Lead Sponsor:

Sihuan Pharmaceutical Holdings Group Ltd.

Treatments:

Rabeprazole